Novel Pharmaceutical Composition Comprising Particles Comprising A Complex Of A Double-Stranded Polyribonucleotide And A Polyalkyleneimine

Patent No. EP3319587 (titled "Novel Pharmaceutical Composition Comprising Particles Comprising A Complex Of A Double-Stranded Polyribonucleotide And A Polyalkyleneimine") was filed by Bioncotech Therapeutics on Nov 17, 2016. The application was issued on Aug 21, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TARGIMMUNE THERAPEUTICSMay 25, 2020LATSCHA SCHOLLHORN PARTNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3319587

BIONCOTECH THERAPEUTICS
Application Number
EP16805990A
Filing Date
Nov 17, 2016
Status
Opposition Rejected
Apr 28, 2023
Publication Date
Aug 21, 2019